Poor
Not Aligned
Patient Risk:
Low
Summary
No FDA-approved prescribing information (label text/sections) was provided in the prompt to validate the AI-generated pricing, insurance/cost-sharing, and assistance-program claims. All claims are unsupported relative to the supplied label evidence.
Category Scores
Accurate Statements
Unsupported Statements
Hydrocortisone cost can vary significantly, with prices often ranging from approximately $20 to over $100 for a single prescription.
Unsupported: no FDA label text/sections were provided to support any pricing figures.
Hydrocortisone pricing is influenced by specific formulation, dosage, quantity, and the pharmacy where it is purchased.
Unsupported: no FDA label text/sections provided addressing pricing determinants.
Generic hydrocortisone versions are generally less expensive than brand-name options.
Unsupported: no FDA label text/sections provided addressing relative pricing of generic vs brand.
Hydrocortisone cost is affected by whether it is a brand-name drug or a generic equivalent, with generics typically more affordable.
Unsupported: no FDA label text/sections provided addressing generic vs brand affordability.
Hydrocortisone strength measured in milligrams can affect cost, with higher strengths sometimes costing more.
Unsupported: no FDA label text/sections provided linking strength to cost.
The quantity of hydrocortisone prescribed (e.g., 30-day supply vs 90-day supply) impacts total cost.
Unsupported: no FDA label text/sections provided regarding quantity-to-cost relationship.
The retail pharmacy where a hydrocortisone prescription is filled can have different pricing structures.
Unsupported: no FDA label text/sections provided addressing pharmacy-specific pricing.
Insurance coverage and the patient's specific plan, including co-pays and deductibles, are major determinants of out-of-pocket expenses for hydrocortisone.
Unsupported: no FDA label text/sections provided addressing insurance plan economics, co-pays, or deductibles.
Comparing prices across different retail pharmacies can reveal significant savings for hydrocortisone.
Unsupported: no FDA label text/sections provided supporting price-comparison/savings claims.
Discount cards or loyalty programs may reduce the price of hydrocortisone.
Unsupported: no FDA label text/sections provided addressing discount cards/loyalty programs.
Prescription discount services and online pharmacies can sometimes provide competitive pricing for hydrocortisone.
Unsupported: no FDA label text/sections provided addressing discount services/online pharmacy pricing.
Insurance provider information about preferred pharmacies or mail-order options may help reduce hydrocortisone cost.
Unsupported: no FDA label text/sections provided addressing preferred pharmacies/mail-order cost reduction.
Hydrocortisone creams can range in price from around $10 to $50 or more for a standard tube.
Unsupported: no FDA label text/sections provided supporting retail price ranges for cream.
The cost of hydrocortisone cream depends on the concentration of hydrocortisone, the size of the tube (e.g., 15g, 30g), and whether it is a prescription or over-the-counter product.
Unsupported: no FDA label text/sections provided addressing retail pricing determinants by concentration/size/prescription status.
Over-the-counter hydrocortisone formulations are generally less expensive than prescription-strength creams.
Unsupported: no FDA label text/sections provided comparing OTC vs prescription pricing.
Most insurance plans cover prescription hydrocortisone, with the patient typically paying a co-payment.
Unsupported: no FDA label text/sections provided supporting general insurance coverage/co-payment statements.
The amount of a hydrocortisone co-payment varies based on the insurance plan's formulary, tier system for medications, and whether a generic or brand-name drug is prescribed.
Unsupported: no FDA label text/sections provided describing formulary/tier-based co-pay mechanics.
Without insurance, the full retail price of hydrocortisone would apply and can be substantially higher.
Unsupported: no FDA label text/sections provided regarding uninsured pricing.
Patient assistance programs may be available for prescription hydrocortisone, particularly for those facing financial hardship.
Unsupported: no FDA label text/sections provided supporting existence/availability of assistance programs.
Pharmaceutical manufacturers may offer programs that provide free or low-cost hydrocortisone to eligible individuals.
Unsupported: no FDA label text/sections provided supporting manufacturer assistance programs.
Non-profit organizations and government programs may offer assistance with prescription medication costs, including hydrocortisone.
Unsupported: no FDA label text/sections provided supporting non-profit/government assistance for hydrocortisone.
Generic hydrocortisone is typically priced much lower than its brand-name counterpart.
Unsupported: no FDA label text/sections provided supporting relative price magnitude.
The cost difference between brand-name and generic hydrocortisone is attributed to reduced research and development costs associated with generic drug production.
Unsupported: no FDA label text/sections provided; additionally, this is an economic rationale not verifiable against the supplied label evidence.
When a patent expires for a brand-name drug, other companies can manufacture generic versions, increasing market competition and driving down prices.
Unsupported: no FDA label text/sections provided.
Contradictions
Important Omissions
Any FDA-label-based information on hydrocortisone indications, dosing/administration, contraindications, boxed warnings, warnings/precautions, drug interactions, adverse reactions, and monitoring.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Claims relate to cost/coverage/access and are not verifiable against FDA prescribing information supplied in the prompt; no direct dosing/safety instructions or contraindications were asserted.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Not Aligned
Primary Issue
All claims are unsupported because no FDA-approved label text/sections were provided to corroborate pricing, insurance/co-pay, and assistance-program statements.
Suggested Improvement
Provide the relevant FDA prescribing information sections (e.g., labeling for indications, dosing, contraindications, warnings, adverse reactions) and restrict assertions to what the label explicitly states; remove or qualify any pricing/insurance/assistance claims that cannot be supported by the provided label.